Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Income Statement [Abstract]
Revenues	$ 498,667	$ 493,774	$ 1,062,065	$ 998,523
Cost of Goods Sold	418,329	382,454	852,254	747,909
Gross Profit	80,338	111,320	209,811	250,614
Research and Development Expenses, net	166,661	149,044	373,952	300,234
Selling, General and Administrative Expenses	268,916	274,718	549,880	528,074
Gain on Sale of Assets	(1,764)	(99)	(3,702)	(2,149)
Total Operating Expenses	433,813	423,663	920,130	826,159
Operating Loss	(353,475)	(312,343)	(710,319)	(575,545)
Gain on Sale of Patents				2,276,286
Non-cash Provision for Claims for Liquidated Damages	(629,000)		(629,000)
Other Income	76,149	176	76,149	533
Interest Expense	(158)	(12,708)	(1,408)	(27,708)
Net Income (loss)	$ (906,484)	$ (324,875)	$ (1,264,578)	$ 1,673,566
Income (Loss) Per Share:
Basic	$ (0.22)	$ (0.27)	$ (0.47)	$ 1.55
Diluted	$ (0.22)	$ (0.27)	$ (0.47)	$ 1.47
Weighted Average Common Shares Outstanding:
Basic	4,035,656	1,191,138	2,688,788	1,081,075
Diluted	4,035,656	1,191,138	2,688,788	1,160,355